Benefytt Technologies, Inc. to be Acquired by Madison Dearborn Partners
TAMPA, Fla., July 13, 2020 (GLOBE NEWSWIRE) — Benefytt Technologies, Inc. (NASDAQ: BFYT) (“Benefytt”) (“the Company”), a health insurance technology […]
Solar Alliance Sales Growth Continues in First Half of 2020
VANCOUVER, British Columbia and KNOXVILLE, Tenn., July 13, 2020 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the […]
Hemlo Explorers Advances Field Work at North Limb Project
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to provide an update […]
MacDonald Mines Announces Further Increase of Flow-Through Private Placement to $4,000,000
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK) (“MacDonald Mines”, “MacDonald” or the “Company”) announces […]
REPEAT – African Gold Group Files NI 43-101 Technical Report for Kobada Gold Project
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) is pleased to […]
Yamana Gold Announces Preliminary Second Quarter 2020 Results; Further Balance Sheet Improvements; Ramp-Up at Canadian Malartic Completed Faster Than Anticipated With Record Tonnes Milled in May
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX: YRI; NYSE: AUY) (“Yamana” or “the Company”) announces preliminary second quarter 2020 results, […]
Major Precious Plans Site Visit to Skaergaard
VANCOUVER, British Columbia, July 13, 2020 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE […]
Second Phase of Beyond Tobacco™ Market Research Underway with NV’s Largest Consumer Product Testing Firm
Following the first retail market testing phase for Beyond Tobacco™ in spring 2020 in which anecdotal user responses were collected […]
Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced positive results […]
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
NDA submission on track for 4Q 2020NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a […]
